The impotence drug Levitra (vardenafil) proved effective for men with diabetes who had not been helped by Viagra (sildenafil). The trial tested Levitra against a placebo in 463 men with moderate to severe erectile dysfunction (ED) who had not responded well to previous treatments with Viagra.
All study participants had previously failed in at least four of the prior six attempts at intercourse with Viagra — including at least one unsuccessful attempt with the highest available dose, 100 milligrams.
Within the trial, researchers looked at a subset of 138 patients with diabetes. The researchers said diabetic men who took Levitra showed a statistically significant advantage compared with those given placebo.
Men with diabetes were able to engage in successful intercourse on 33% of attempts with Levitra, compared with only 6% of attempts before treatment.
"This study is important because it shows that vardenafil is a successful treatment option for ED in the difficult-to-treat diabetic population, in whom other treatments often have not been successful," said Dr. Alan Garber, professor of medicine, biochemistry and molecular biology at Baylor College of Medicine.
Presented at ADA 64th Annual Scientific Sessions
===========================
|
The First Step Program© is now available in the U.S. The only walking program that has gone through clinical studies and has been published in scientific journals showing its effectiveness in increasing physical activity. Start the New Year by taking the First Step to better health for your patients. www.firststepprogram.com Then go to www.firststeptracker.com and have access to your patients steps/day information. |
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.